HAMILTON THORNE TO PRESENT AT RODMAN & RENSHAW ANNUAL INVESTMENT CONFERENCE
ON SEPTEMBER 15

TSX VENTURE: HTL

TORONTO, Sept. 8 /CNW/ - Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of advanced laser systems for the regenerative medicine, developmental biology and stem cell research markets, today announced that Meg Spencer, the Company's Chief Executive Officer and Co-Founder, will present at the Rodman & Renshaw Annual Investment Conference on September 15 at 9:35 am in the Spellman Salon of the New York Palace Hotel, New York.

To access Hamilton Thorne's presentation via webcast and for more information on the conference please visit http://www.rodmanandrenshaw.com/conferences?id=51.

About Hamilton Thorne Ltd. (www.hamiltonthorne.com)

Hamilton Thorne's advanced laser systems and instruments are rapidly emerging as the dominant products to facilitate precise procedures in the stem cell research and fertility clinic markets. Hamilton Thorne's lead products, the ZILOS-tk and XYClone laser systems, attach to standard inverted microscopes and operate as robotic micro-surgeons, significantly reducing time and increasing efficiency in key in-vitro fertilization, stem cell, embryo, reproductive toxicology, and living cell procedures.

Hamilton Thorne's growing customer base includes pharmaceutical companies, biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Current customers include world-leading research labs such as Harvard University, MIT, Yale, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, Oxford University, and Cambridge.

Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.

Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available at www.sedar.com.

%SEDAR: 00025407E

For further information: David Wolf, President, Hamilton Thorne Ltd., 978-299-1715, [email protected]; Ross Marshall, The Equicom Group, 416.815.0700 x238, [email protected]